Genetic variation in RNASEL associated with prostate cancer risk and progression (Q34094981)

31 July 2017

Genetic variation in RNASEL associated with prostate cancer risk and progression (English)

1 reference

31 July 2017

1 reference

1 reference

Stephen Finn

8

0 references

Jennifer R Stark

Jennifer R Stark

3

0 references

Katja Fall

Katja Fall

13

0 references

Tobias Kurth

Tobias Kurth

10

0 references

Richard Flavin

Richard J Flavin

9

0 references

Lorelei A. Mucci

16

Lorelei A Mucci

1 reference

31 July 2017

6

Massimo Loda

1 reference

31 July 2017

14

Meir J Stampfer

1 reference

31 July 2017

12

Edward L Giovannucci

1 reference

31 July 2017

Michelangelo Fiorentino

7

Michelangelo Fiorentino

1 reference

31 July 2017

2

Kathryn L Penney

1 reference

31 July 2017

5

Howard D Sesso

1 reference

31 July 2017

4

Fredrick R Schumacher

1 reference

31 July 2017

11

Alkes L Price

1 reference

31 July 2017

Mara S Meyer

1

1 reference

31 July 2017

Jing Ma

15

1 reference

31 July 2017

language of work or name

English

0 references

publication date

24 June 2010

1 reference

31 July 2017

1 reference

31 July 2017

31

1 reference

31 July 2017

9

1 reference

31 July 2017

1597-1603

1 reference

Single and multivariate associations of MSR1, ELAC2, and RNASEL with prostate cancer in an ethnic diverse cohort of men.

31 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930803

Identification of a new prostate cancer susceptibility locus on chromosome 8q24.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930803

Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930803

Genetic variants and prostate cancer risk: candidate replication and exploration of viral restriction genes.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930803

Association of IL10 and other immune response- and obesity-related genes with prostate cancer in CLUE II.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930803

C-reactive protein, interleukin-6, and prostate cancer risk in men aged 65 years and older

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930803

Circulating prediagnostic interleukin-6 and C-reactive protein and prostate cancer incidence and mortality

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930803

Prevalence of human gammaretrovirus XMRV in sporadic prostate cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930803

Association of HPC2/ELAC2 and RNASEL non-synonymous variants with prostate cancer risk in African American familial and sporadic cases

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930803

No association between a polymorphic variant of the IRS-1 gene and prostate cancer risk

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930803

Correlates of circulating C-reactive protein and serum amyloid A concentrations in breast cancer survivors

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930803

Multiple loci identified in a genome-wide association study of prostate cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930803

RNASEL and RNASEL-inhibitor variation and prostate cancer risk in Afro-Caribbeans.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930803

A scientific journey through the 2-5A/RNase L system

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930803

Inflammation in prostate carcinogenesis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930803

RETRACTED: Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930803

SNP500Cancer: a public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930803

C-reactive protein levels are not associated with increased risk for colorectal cancer in women

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930803

HPC1/RNASEL mediates apoptosis of prostate cancer cells treated with 2',5'-oligoadenylates, topoisomerase I inhibitors, and tumor necrosis factor-related apoptosis-inducing ligand.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930803

Prostate carcinogenesis and inflammation: emerging insights.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930803

C-reactive protein and the risk of incident colorectal cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930803

Role of genetic polymorphisms of the RNASEL gene on familial prostate cancer risk in a Japanese population

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930803

A novel founder mutation in the RNASEL gene, 471delAAAG, is associated with prostate cancer in Ashkenazi Jews

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930803

Germline mutations in the ribonuclease L gene in families showing linkage with HPC1

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930803

Elevated levels of circulating interleukin-6 and transforming growth factor-beta1 in patients with metastatic prostatic carcinoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930803

Interferon action and apoptosis are defective in mice devoid of 2',5'-oligoadenylate-dependent RNase L

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930803

Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930803

Prospective study of sex hormone levels and risk of prostate cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930803

Molecular evolution of the prostate cancer susceptibility locus RNASEL: evidence for positive selection.

5 July 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ132

RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ132

Association of susceptibility alleles in ELAC2/HPC2, RNASEL/HPC1, and MSR1 with prostate cancer severity in European American and African American men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ132

C-reactive protein as a prognostic marker for men with androgen-independent prostate cancer: results from the ASCENT trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ132

C-reactive protein is significantly associated with prostate-specific antigen and metastatic disease in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ132

RNASEL Arg462Gln polymorphism and prostate cancer in PLCO

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ132

Association of hereditary prostate cancer gene polymorphic variants with sporadic aggressive prostate carcinoma

21 January 2018

1 reference

12 December 2020

RNASEL gene polymorphisms and the risk of prostate cancer: a meta-analysis

1 reference

12 December 2020

DNA variation in MSR1, RNASEL and E-cadherin genes and prostate cancer in Poland

1 reference

12 December 2020

Association of RNASEL variants with prostate cancer risk in Hispanic Caucasians and African Americans

1 reference

12 December 2020

Identifiers

DOI

10.1093/CARCIN/BGQ132

1 reference

31 July 2017

1 reference

31 July 2017

1 reference